Serum amyloid A (SAA) treatment enhances the recovery of aggravated 
polymicrobial sepsis in mice, whereas blocking SAA's invariant peptide results 
in early death

Linke, Reinhold P.; Meinel, Angelika; Chalcroft, James P.; Urieli-Shoval, Simcha

doi:10.1080/13506129.2017.1295950

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_2464967_5

DetailsSummary

Released

Journal Article

Serum amyloid A (SAA) treatment enhances the recovery of aggravated polymicrobial sepsis in mice, whereas blocking SAA's invariant peptide results in early death

MPS-Authors

/persons/resource/persons77846

Chalcroft, James P.
MPI of Neurobiology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Linke, R. P., Meinel, A., Chalcroft, J. P., & Urieli-Shoval, S. (2017). Serum amyloid A (SAA) treatment enhances the recovery of aggravated polymicrobial sepsis in mice, whereas blocking SAA's invariant peptide results in early death. Amyloid-Journal of Protein Folding Disorders, 24, 149-150. doi:10.1080/13506129.2017.1295950.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002D-BB0E-5

Abstract

There is no abstract available